| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/21/2011 | US7964397 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 06/21/2011 | US7964395 Modified vaccinia ankara virus variant and cultivation method |
| 06/21/2011 | US7964382 DNA encoding a protein having D-lactate dehydrogenase activity and uses thereof |
| 06/21/2011 | US7964375 Polynucleotides encoding human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 06/21/2011 | US7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/21/2011 | US7964200 Methods and compositions for immunizing against Chlamydia infection |
| 06/21/2011 | US7964195 Using immunoglobulin which preferentially binds cancer specific antigen (OVR110) as treatment for head and neck or endometrial cancer |
| 06/21/2011 | CA2516270C Oxadiazoline and thiadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/21/2011 | CA2386471C Purification of recombinant proteins fused to multiple epitopes |
| 06/21/2011 | CA2340328C Stable hypoxia inducible factor-1 alpha and method of use |
| 06/21/2011 | CA2299442C Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 06/21/2011 | CA2297408C Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| 06/21/2011 | CA2198966C Method for cleaving chimeric protein using processing enzyme |
| 06/21/2011 | CA2172392C Methods of inhibiting phagocytosis |
| 06/21/2011 | CA2171336C Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 06/16/2011 | WO2011072006A1 Method of reversing immune suppression of langerhans cells |
| 06/16/2011 | WO2011071926A1 Bche albumin fusions for the treatment of cocaine abuse |
| 06/16/2011 | WO2011071147A1 Novel expression vector, and process for production of protein using the vector |
| 06/16/2011 | WO2011070776A1 Method and device for synthesizing protein from dna molecule captured in microchamber |
| 06/16/2011 | WO2011069227A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/16/2011 | US20110145938 Method for generating monoclonal antibodies that recognize progenitor cells |
| 06/16/2011 | US20110145937 Mice That Make Heavy Chain Antibodies |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144306 Ligation of stapled polypeptides |
| 06/16/2011 | US20110144302 Polypeptide |
| 06/16/2011 | US20110144025 Methods of Reducing Hemorrhage Due to Surgical Procedure |
| 06/16/2011 | US20110144015 Methods for treating muscle diseases and disorders |
| 06/16/2011 | US20110143954 Gamma-secretase substrate and methods of use |
| 06/16/2011 | US20110143940 Streptomyces beta-vulgaris strain, culture filtrate, derived active compounds and use thereof in the treatment of plants |
| 06/16/2011 | US20110143443 Isolsted Monoclonal - Associated Protein Tau and Kit |
| 06/16/2011 | US20110143440 Mutations caused by activation-induced cytidine deaminase |
| 06/16/2011 | US20110143397 Rna preparations comprising purified modified rna for reprogramming cells |
| 06/16/2011 | US20110143396 Vectors and yeast strains for protein production: ca2+ atpase overexpression |
| 06/16/2011 | US20110143377 Protein fragments of virB10 and sero-detection of anaplasma phagocytophium |
| 06/16/2011 | US20110142871 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 06/16/2011 | US20110142870 Bacillus anthracis antigens, vaccine compositions, and related methods |
| 06/16/2011 | US20110142865 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142852 Multispecific antibodies |
| 06/16/2011 | US20110142847 Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 |
| 06/16/2011 | US20110142845 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF |
| 06/16/2011 | US20110142843 Fetal polypeptides from human liver |
| 06/16/2011 | US20110142841 Compositions and methods for the treatment of systemic lupus erythematosis |
| 06/16/2011 | US20110142825 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | CA2782970A1 Method and device for synthesizing proteins from dna molecules captured in microchambers |
| 06/16/2011 | CA2781883A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/15/2011 | EP2333099A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333098A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333097A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333096A2 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 06/15/2011 | EP2333095A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 06/15/2011 | EP2333083A1 Production of high mannose human glucocerebrosidease in plant culture |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/15/2011 | EP2333050A1 B cell-derived ips cells and application thereof |
| 06/15/2011 | EP2332993A1 Human monoclonal antibody to the human epidermal growth factor receptor |
| 06/15/2011 | EP2332982A1 Liver X receptor alpha splicing mutant protein, gene thereof and utilization of the same |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332975A1 Human proteins |
| 06/15/2011 | EP2332974A2 Osteoprotegerin |
| 06/15/2011 | EP2332896A2 Evolving new molecular function |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332561A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/15/2011 | EP2332531A1 Apo2 ligand/TRAIL formulations |
| 06/15/2011 | EP2331701A1 Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof |
| 06/15/2011 | EP2331700A2 Nutrient monitoring and feedback control for increased bioproduct production |
| 06/15/2011 | EP1907854B1 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase |
| 06/15/2011 | EP1880009B1 Highly productive recombinant yeast strains with modified galactose-regulated transcription |
| 06/15/2011 | EP1476462B1 Novel fungal lipase |
| 06/15/2011 | EP1417344B1 Zinc finger domain libraries |
| 06/15/2011 | EP1417229B1 Methods and compounds for the targeting of protein to exosomes |
| 06/15/2011 | EP1404710B1 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 06/15/2011 | EP1282722B1 Stabilized proteins |
| 06/15/2011 | EP1012274B2 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l) |
| 06/15/2011 | EP0939804B2 NEUTROKINE alpha |
| 06/15/2011 | CN201864728U Protein processing and digesting tank |
| 06/15/2011 | CN1820734B Treatment with anti-erbb2 antibodies |
| 06/15/2011 | CN1780907B Anti-CCR5 antibody |
| 06/15/2011 | CN1680432B Viral protein |
| 06/15/2011 | CN1452656B Lipoxygenase |
| 06/15/2011 | CN1452636B Human monoclonal antibodies to dendritis cells |
| 06/15/2011 | CN102099468A Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 06/15/2011 | CN102094060A Method for producing pressure reduction peptide from soybean as raw material |
| 06/15/2011 | CN102094059A Method for preparing soybean polypeptide by microwave-promoted hydrolysis of soybean protein |
| 06/15/2011 | CN102094058A Method for preparing fish skin collagen polypeptide by promoting hydrolysis of fish skin with microwaves |
| 06/15/2011 | CN102094057A Method for preparing ovalbumin polypeptide by microwave-promoted enzymolysis |
| 06/15/2011 | CN102094056A Method for preparing soluble collagen |
| 06/15/2011 | CN102094055A Method for preparing active toxin by using Bacillus thuringiensis fermentation liquid |
| 06/15/2011 | CN102094054A Production method of Bacillus subtilis antimicrobial lipopeptide and application of Bacillus subtilis antimicrobial lipopeptide in piglet feeds |
| 06/15/2011 | CN102094039A Prokaryotic expression and purification method of transgenic rice Bt protein cry2a |
| 06/15/2011 | CN102094038A Prokaryotic expression and purification method of transgenic rice Bt protein crylc |
| 06/15/2011 | CN102093998A Preparation method of antibacterial peptide cecropin feed additive |
| 06/15/2011 | CN102093993A Kringle 5 mutant protein, and preparation method and application thereof |
| 06/15/2011 | CN102093479A Recombinant chimeric antibody of anti-human vascular endothelium growth factor receptor 2 |
| 06/15/2011 | CN102093471A Angiotensin I transferase inhibitor and preparation method and application thereof |
| 06/15/2011 | CN102093440A Coproduction process of pig brain protein hydrolysate and monosialoganglioside |
| 06/15/2011 | CN101608182B Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/15/2011 | CN101407768B Saccharomyces cerevisiae mutant bacterial strain and use thereof in glutathion production by fermentation |